Same Indication

Nivolumab vs Sacubitril-Valsartan

Nivolumab vs Sacubitril-Valsartan: Overview

This comparison examines the pharmacological differences between Nivolumab and Sacubitril-Valsartan.

Mechanism of Action

Nivolumab: Fully human anti-PD-1 IgG4 monoclonal antibody restoring T-cell anti-tumor activity.

Sacubitril-Valsartan: Angiotensin receptor-neprilysin inhibitor (ARNI) combining neprilysin inhibition with AT1 receptor blockade.

Pharmacokinetics

Half-life: Nivolumab β€” 27 days; Sacubitril-Valsartan β€” 11.5 hours.

Chemical Properties

Molecular Formula: Sacubitril-Valsartan β€” C24H29N2O5.

Molecular Weight: Sacubitril-Valsartan β€” 414.5010 g/mol.

Type: Nivolumab β€” Antibody; Sacubitril-Valsartan β€” Small molecule.